Kallyope enters Phase II with obesity and diabetes tablet
New York-based Kallyope is one step closer to the billion-dollar markets for the treatment of obesity and diabetes.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.